HomeBLRX • NASDAQ
add
BioLine RX Ltd - ADR
Previous close
$3.45
Day range
$3.40 - $3.56
Year range
$2.30 - $14.70
Market cap
14.40M USD
Avg Volume
26.74K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 427.00K | -91.36% |
Operating expense | 2.55M | -73.18% |
Net income | -977.00K | 83.22% |
Net profit margin | -228.81 | -94.27% |
Earnings per share | 0.00 | — |
EBITDA | -2.09M | 54.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.21M | -13.58% |
Total assets | 39.80M | -24.53% |
Total liabilities | 20.27M | -54.18% |
Total equity | 19.53M | — |
Shares outstanding | 2.61B | — |
Price to book | 344.50 | — |
Return on assets | -13.28% | — |
Return on capital | -17.35% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -977.00K | 83.22% |
Cash from operations | -2.11M | 78.56% |
Cash from investing | 3.67M | -63.90% |
Cash from financing | -916.00K | 24.79% |
Net change in cash | 725.00K | 192.12% |
Free cash flow | -2.76M | 65.11% |
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Website
Employees
28
